This HTML5 document contains 219 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/
n8http://dx.doi.org/10.1128/

Statements

Subject Item
wd:Q33668265
rdf:type
wikibase:Item
schema:description
teaduslik artikkel 1998年論文 wetenschappelijk artikel บทความทางวิทยาศาสตร์ tieteellinen artikkeli مقالة علمية article scientifique (publié 1998) 1998 nî lūn-bûn bài báo khoa học 1998年論文 artigo científico vetenskaplig artikel مقالهٔ علمی мақолаи илмӣ наукова стаття, опублікована в червні 1998 1998年論文 mokslinis straipsnis 1998年论文 מאמר מדעי научна статия article científic artikull shkencor artigo científico (publicado na 1998) επιστημονικό άρθρο videnskabelig artikel (udgivet 1998) vedecký článok 1998 թուականի Յունիսին հրատարակուած գիտական յօդուած wissenschaftlicher Artikel научни чланак articolo scientifico article scientific scienca artikolo ১৯৯৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ scientific article 1998 թվականի հունիսին հրատարակված գիտական հոդված 1998年论文 სამეცნიერო სტატია vědecký článek 1998年论文 bilimsel makale 1998年の論文 vitenskapelig artikkel artykuł naukowy 1998年論文 articol științific 1998年论文 научни чланак vitskapeleg artikkel artículu científicu espublizáu en 1998 1998년 논문 1998年论文 1998年論文 naučni članak artículo científico publicado en 1998 1998年论文 سائنسی مضمون научная статья artikulong pang-agham мақолаи илмӣ artigo científico (publicado na 1998) tudományos cikk
p:P577
wds:Q33668265-95A01C1A-4D75-4B7E-AD5B-CD0DAA4FD6FC
wdt:P577
1998-06-01T00:00:00Z
p:P407
wds:Q33668265-88800197-30D7-4932-9D7E-865B09791478
wdt:P407
wd:Q1860
p:P2860
wds:Q33668265-623A3145-9A1C-43E2-8925-37514E0B52CE wds:Q33668265-659E93A1-3DFB-4EF2-9C6F-2296900C8952 wds:Q33668265-5E3F41A4-E0BA-4318-94A7-51D877D4723A wds:Q33668265-602CDFCB-2B2C-497E-BAAB-D5558480E515 wds:Q33668265-7F824F70-D0DD-436D-8608-119450B3F699 wds:Q33668265-775FF19B-FF3C-4D7B-B493-740C2A3924E1 wds:Q33668265-78A36E12-E10E-4EE5-81DB-EC7D9B4A998B wds:Q33668265-9B19EBC1-C9D0-4013-90DF-6FFB6B15E593 wds:Q33668265-A21809EE-EE67-4065-A94F-8442C81413F6 wds:Q33668265-88BD7C6F-4AE0-4F03-B767-FD5E2F73CED3 wds:Q33668265-959F95D9-8A83-42F4-83BB-A2C71586AA79 wds:Q33668265-AEE7CB14-84A6-4A2A-97EE-0B1BD0330C4F wds:Q33668265-BB23FE0B-01E7-47F6-B6D9-E84D97687832 wds:Q33668265-A5219A7C-CDF2-4B55-A6C1-BEAD53A5EFB9 wds:Q33668265-ADCA8249-6A55-48DD-9EF8-8A3047D1B760 wds:Q33668265-AE1B7436-EB80-45E9-AE27-D5BDD03B7F8C wds:Q33668265-0EF40870-2004-4D03-ABE7-6087187150E9 wds:Q33668265-0F70DB9D-6A13-4958-8A25-CA8D642EAA64 wds:Q33668265-31230037-1B80-4F6C-AC33-2304EB2ACA44 wds:Q33668265-33F6B01B-EF03-40A7-B005-37930F738120 wds:Q33668265-151223EA-35D0-4138-90EC-B227B2D87BB6 wds:Q33668265-174402EA-296E-4C55-B584-E411722D88DD wds:Q33668265-4249CEEB-BC6D-4381-9979-62A700D39311 wds:Q33668265-4177BC90-D090-41BF-A6D2-932E942C41EA wds:Q33668265-CEDC6D94-4C24-4FD2-89AA-EB5C4A23C9CE wds:Q33668265-CA7A8565-1EDC-43B1-8A12-7BAF87D556E6 wds:Q33668265-CD00C5B3-6B67-4251-A363-7EDF9DBE39C4 wds:Q33668265-E6F01386-34DF-46A8-8458-BD434842632D wds:Q33668265-E7DFEB8C-8D0F-45FF-9925-5EAC9B7687B5 wds:Q33668265-E8734527-44CB-48EF-A683-787E6FF38166 wds:Q33668265-D4526741-E301-4667-BE90-9C3DA76CB1B6 wds:Q33668265-DB1EF9C2-E3D1-4D75-A329-F9DE2B793F8A wds:Q33668265-DD4D7B23-7A79-4DF7-B4F5-9FE70F6558C8 wds:Q33668265-F16514B7-317A-4F30-ACD3-2A5F1E9A1FD4 wds:Q33668265-F37D548C-EF43-445A-9240-F427DF03F1F8
wdt:P2860
wd:Q45783301 wd:Q45763443 wd:Q33661973 wd:Q45757928 wd:Q36829703 wd:Q71726486 wd:Q36542226 wd:Q45761943 wd:Q34073785 wd:Q33647718 wd:Q45783125 wd:Q45786423 wd:Q38888534 wd:Q45767591 wd:Q40631528 wd:Q36547353 wd:Q57231820 wd:Q36543907 wd:Q40014818 wd:Q56791561 wd:Q24606530 wd:Q36542026 wd:Q36541331 wd:Q72624142 wd:Q29619980 wd:Q37882121 wd:Q44142380 wd:Q45763459 wd:Q36522763 wd:Q45762216 wd:Q34736939 wd:Q29615124 wd:Q36531631 wd:Q50595390 wd:Q61111961
p:P2093
wds:Q33668265-FE970D31-9189-4ED3-854D-87F4EEB86BC8 wds:Q33668265-CA45BCEB-6F13-45AA-A4FC-24FD514339B8 wds:Q33668265-CE19D6EA-E31F-41A8-B2CA-4A836627DE96 wds:Q33668265-CE35E8CB-0EFB-4C3D-982B-43B9616218F7 wds:Q33668265-E4F2B4C9-F8A9-4550-B537-30D2FD448428 wds:Q33668265-1F52DD24-C593-4622-8314-F4BD64F3EAC8 wds:Q33668265-0FE2C0D1-0B1E-4028-855A-5EAED27B06CD wds:Q33668265-32ADAE23-FCBB-4E2A-A6A1-90467CA6B416 wds:Q33668265-22740E9B-3BA5-4759-AD4A-D01685F5FB5B wds:Q33668265-3FED2366-B7C6-46A5-B861-A28ACE4111FA wds:Q33668265-5932FA1A-FA53-4E19-8FC7-53392E3D3C68 wds:Q33668265-5D5DD0E9-85B4-4E1D-B2E4-35206FF87FEA wds:Q33668265-5006BF21-F8FA-4D5B-B5E6-570A0DA84BC1 wds:Q33668265-9F78B2C9-47DC-4670-8E53-CCD1BB7A010B wds:Q33668265-AB2761F1-411D-4233-A9C8-F116E7FF583A wds:Q33668265-C9285F9C-985E-4CAE-B6A5-4B3A1F33C8FB wds:Q33668265-5DD947D2-0984-4016-9D09-A3DF7D8F0661 wds:Q33668265-6C854724-E45F-4920-AD24-BBFFA4883A08 wds:Q33668265-6149339B-A35A-4653-B025-C8FF97FA3EBB wds:Q33668265-7CADC43B-9704-42A6-8393-443749462EE7 wds:Q33668265-82FA552C-2679-4908-835D-0FE2EB0F1BD2 wds:Q33668265-801129F2-0D49-4367-B88D-FFB27C89B5F7 wds:Q33668265-FD083073-41BF-4BF7-9B59-D313423E6A18
wdt:P2093
J Moye D Chernoff B Weiser S Fiscus J Bremer A Kovacs T Yeghiazarian R Dickover R Carrol P Reichelderfer J Kornegay M Fowler M Cronin S Herman K McIntosh M Robb S Cassol B Jackson W Meyer T Quinn M Vahey N Michael J Lew
rdfs:label
Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics
skos:prefLabel
Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics
schema:name
Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics
p:P50
wds:Q33668265-EF530510-5E04-41FD-9165-B9070A47F58A wds:Q33668265-FEF4EF48-FEC1-43E6-9BE6-38A80B95EE18
wdt:P50
wd:Q98719827 wd:Q43882680
p:P1476
wds:Q33668265-365B2ACD-91EF-4028-9B96-D88AD98D5489
wdt:P1476
Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics
p:P304
wds:Q33668265-CB946856-D799-4EA9-A861-B3F56B57C5F7
wdt:P304
1471-1479
p:P31
wds:Q33668265-b67b328e-6c61-473c-b112-8eb8efc13153 wds:Q33668265-CF6E6EAB-4179-43E2-8141-FFFDD6F11FC6
wdt:P31
wd:Q13442814 wd:Q7318358
p:P921
wds:Q33668265-61077579-E9A2-426E-AF3E-D07332C2E9C8
wdt:P921
wd:Q27556165
p:P698
wds:Q33668265-D0C10DF6-EC12-43D9-B593-5347097B676B
wdtn:P698
n12:9620364
wdt:P698
9620364
p:P1433
wds:Q33668265-95BEDA47-EC38-4185-BEBD-821250ACE773
wdt:P1433
wd:Q4041880
p:P433
wds:Q33668265-C91F682C-0B3A-41B8-9315-F4B5F81979B3
p:P478
wds:Q33668265-3DB38168-F425-44CE-86C7-D7068AE3F878
wdt:P433
6
wdt:P478
36
p:P356
wds:Q33668265-9296B000-EB5E-442B-BC33-7D4FA643F70C
wdtn:P356
n8:JCM.36.6.1471-1479.1998
wdt:P356
10.1128/JCM.36.6.1471-1479.1998
p:P932
wds:Q33668265-7DBB8371-C524-4AE3-ABD9-EB9F856CF5F1
wdt:P932
104860